Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

A holistic approach combining medical, surgical, and psychological therapies is essential for effectively managing diabetes.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

South African wild foods may help prevent cardiovascular disease.

EGCG in green tea benefits skin, hair, cancer treatment, weight loss, diabetes, heart, and brain health.

Mediterranean Erica plants may help with inflammation, infections, and weight loss due to their bioactive compounds.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Women with PCOS have higher levels of thyroid autoantibodies.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Mediterranean Erica species have compounds that support their traditional use for health benefits like reducing inflammation and fighting infections.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

New medications could improve treatment for severe alopecia areata in Australia.

Women with PCOS have a higher risk of heart disease.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.